Page last updated: 2024-09-03

carglumic acid and Carbamoyl-Phosphate Synthase I Deficiency Disease

carglumic acid has been researched along with Carbamoyl-Phosphate Synthase I Deficiency Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ah Mew, N; Daikhin, Y; Lichter-Konecki, U; McCarter, R; Nissim, I; Tuchman, M; Yudkoff, M1
Ah Mew, N; Shi, D; Tuchman, M; Zhao, G1
Diez-Fernandez, C; Häberle, J1

Reviews

1 review(s) available for carglumic acid and Carbamoyl-Phosphate Synthase I Deficiency Disease

ArticleYear
Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.
    Expert opinion on therapeutic targets, 2017, Volume: 21, Issue:4

    Topics: Animals; Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Genetic Therapy; Glutamates; Humans; Molecular Chaperones; Mutation; Urea Cycle Disorders, Inborn

2017

Trials

1 trial(s) available for carglumic acid and Carbamoyl-Phosphate Synthase I Deficiency Disease

ArticleYear
Augmenting ureagenesis in patients with partial carbamyl phosphate synthetase 1 deficiency with N-carbamyl-L-glutamate.
    The Journal of pediatrics, 2014, Volume: 165, Issue:2

    Topics: Adolescent; Adult; Ammonia; Carbamoyl-Phosphate Synthase I Deficiency Disease; Child; Child, Preschool; Female; Glutamates; Glutamine; Humans; Linear Models; Male; Mass Spectrometry; Treatment Outcome; Urea; Young Adult

2014

Other Studies

1 other study(ies) available for carglumic acid and Carbamoyl-Phosphate Synthase I Deficiency Disease

ArticleYear
Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.
    Molecular genetics and metabolism, 2017, Volume: 120, Issue:3

    Topics: Adenosine Triphosphate; Animals; Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Drug Therapy, Combination; Female; Glutamates; Humans; Male; Mice; Mutation; Precision Medicine; Protein Stability; Protein Structure, Tertiary; Rare Diseases

2017